Last 12 months
Inside the activity.
0 purchase rows · 53 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 11 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2025 Filed Mar 10, 2025 21:47 UTC |
Troendle August J.Director · CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 234,259 | $0.00 Strike: $56.61 | $0.00 |
DisclosureSEC source: 0001668397-25-000033 · wk-form4_1741643264.xml · derivative · entry 7 Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 234,259 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 21:47 UTC |
Troendle August J.Director · CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 37,417 | $0.00 Strike: $54.74 | $0.00 |
DisclosureSEC source: 0001668397-25-000033 · wk-form4_1741643264.xml · derivative · entry 6 Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,417 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 21:47 UTC |
Troendle August J.Director · CEO · 10% owner
|
Exercise / conversionCommon Stock | 84,770 | $107.93 | $9,149,226.10 |
DisclosureSEC source: 0001668397-25-000033 · wk-form4_1741643264.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,011,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 21:47 UTC |
Troendle August J.Director · CEO · 10% owner
|
Exercise / conversionCommon Stock | 234,259 | $56.61 | $13,261,401.99 |
DisclosureSEC source: 0001668397-25-000033 · wk-form4_1741643264.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 926,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 21:47 UTC |
Troendle August J.Director · CEO · 10% owner
|
Exercise / conversionCommon Stock | 37,417 | $54.74 | $2,048,206.58 |
DisclosureSEC source: 0001668397-25-000033 · wk-form4_1741643264.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:11 UTC |
Brady Kevin M.CFO & Treasurer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,591 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000023 · wk-form4_1741641071.xml · derivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,591 Underlying: Common Stock · 6,591 shares Expires 2032-03-06 F1 · derivative.exercise_date: The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:47 UTC |
Troendle August J.Director · CEO · 10% owner
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 73,443 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000033 · wk-form4_1741643264.xml · derivative · entry 5 Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,443 Underlying: Common Stock · 73,443 shares Expires 2034-03-06 F2 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:24 UTC |
GEIGER JESSE JPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,886 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000029 · wk-form4_1741641840.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,886 Underlying: Common Stock · 9,886 shares Expires 2032-03-06 F1 · derivative.exercise_date: The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:20 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,591 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000027 · wk-form4_1741641636.xml · derivative · entry 2 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,591 Underlying: Common Stock · 6,591 shares Expires 2032-03-06 F1 · derivative.exercise_date: The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:16 UTC |
BURWIG SUSAN EExec. VP, Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,017 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000025 · wk-form4_1741641383.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,017 Underlying: Common Stock · 11,017 shares Expires 2034-03-06 F1 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:39 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
PurchaseCommon Stock | 2 | $326.11 | $652.22 |
DisclosureSEC source: 0001668397-25-000021 · wk-form4_1740778736.xml · nonDerivative · entry 1 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,343 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:18 UTC |
Carley Brian TDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,127 | $0.00 Strike: $42.62 | $0.00 |
DisclosureSEC source: 0001668397-25-000019 · wk-form4_1740604724.xml · derivative · entry 3 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,127 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 16, 2019. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:18 UTC |
Carley Brian TDirector
|
SaleCommon Stock | 4,003 | $345.59 | $1,383,396.77 |
DisclosureSEC source: 0001668397-25-000019 · wk-form4_1740604724.xml · nonDerivative · entry 2 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,032 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $344.798 to $346.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:18 UTC |
Carley Brian TDirector
|
Exercise / conversionCommon Stock | 8,127 | $42.62 | $346,372.74 |
DisclosureSEC source: 0001668397-25-000019 · wk-form4_1740604724.xml · nonDerivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:26 UTC |
Carley Brian TDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 78 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000002 · wk-form4_1735939599.xml · derivative · entry 2 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:26 UTC |
Carley Brian TDirector
|
Exercise / conversionCommon Stock | 78 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000002 · wk-form4_1735939599.xml · nonDerivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:45 UTC |
McCarthy Cornelius P. IIIDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000006 · wk-form4_1735940744.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:45 UTC |
McCarthy Cornelius P. IIIDirector
|
Exercise / conversionCommon Stock | 62 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000006 · wk-form4_1735940744.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:36 UTC |
Kraft Robert O.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-25-000004 · wk-form4_1735940180.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:36 UTC |
Kraft Robert O.Director
|
Exercise / conversionCommon Stock | 71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-25-000004 · wk-form4_1735940180.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 662 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:24 UTC |
GEIGER JESSE JPresident
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0001668397-24-000178 · wk-form4_1733865891.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on February 28, 2022. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:24 UTC |
GEIGER JESSE JPresident
|
Exercise / conversionCommon Stock | 15,000 | $32.05 | $480,750.00 |
DisclosureSEC source: 0001668397-24-000178 · wk-form4_1733865891.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:20 UTC |
Carley Brian TDirector
|
GrantRestricted Stock Unit · Derivative | 249 | $340.63 | $84,816.87 |
DisclosureSEC source: 0001668397-24-000172 · wk-form4_1733260834.xml · derivative · entry 2 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249 Underlying: Common Stock · 249 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:36 UTC |
McCarthy Cornelius P. IIIDirector
|
GrantRestricted Stock Unit · Derivative | 198 | $340.63 | $67,444.74 |
DisclosureSEC source: 0001668397-24-000176 · wk-form4_1733261772.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198 Underlying: Common Stock · 198 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:28 UTC |
Kraft Robert O.Director
|
GrantRestricted Stock Unit · Derivative | 227 | $340.63 | $77,323.01 |
DisclosureSEC source: 0001668397-24-000174 · wk-form4_1733261284.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227 Underlying: Common Stock · 227 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:40 UTC |
BURWIG SUSAN EExec. VP, Operations
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0001668397-24-000170 · wk-form4_1732225202.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2025-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on February 28, 2022. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:40 UTC |
BURWIG SUSAN EExec. VP, Operations
|
Exercise / conversionCommon Stock | 7,500 | $32.05 | $240,375.00 |
DisclosureSEC source: 0001668397-24-000170 · wk-form4_1732225202.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:27 UTC |
Carley Brian TDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 78 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000157 · wk-form4_1727900855.xml · derivative · entry 2 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78 Underlying: Common Stock · 78 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:27 UTC |
Carley Brian TDirector
|
Exercise / conversionCommon Stock | 78 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000157 · wk-form4_1727900855.xml · nonDerivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:41 UTC |
McCarthy Cornelius P. IIIDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000161 · wk-form4_1727901687.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62 Underlying: Common Stock · 62 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:41 UTC |
McCarthy Cornelius P. IIIDirector
|
Exercise / conversionCommon Stock | 62 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000161 · wk-form4_1727901687.xml · nonDerivative · entry 1 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:35 UTC |
Kraft Robert O.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000159 · wk-form4_1727901296.xml · derivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71 Underlying: Common Stock · 71 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:35 UTC |
Kraft Robert O.Director
|
Exercise / conversionCommon Stock | 71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000159 · wk-form4_1727901296.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:37 UTC |
Kraft Robert O.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,774 | $0.00 Strike: $42.62 | $0.00 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · derivative · entry 6 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,774 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in full on May 16, 2019. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:37 UTC |
Kraft Robert O.Director
|
SaleCommon Stock | 3,774 | $390.73 | $1,474,615.02 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 4 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 20:37 UTC |
Kraft Robert O.Director
|
Exercise / conversionCommon Stock | 3,774 | $42.62 | $160,847.88 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 3 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:37 UTC |
Kraft Robert O.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,353 | $0.00 Strike: $42.62 | $0.00 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · derivative · entry 5 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,774 Underlying: Common Stock · 4,353 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in full on May 16, 2019. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:37 UTC |
Kraft Robert O.Director
|
SaleCommon Stock | 4,353 | $390.73 | $1,700,847.69 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 2 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.055. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 20:37 UTC |
Kraft Robert O.Director
|
Exercise / conversionCommon Stock | 4,353 | $42.62 | $185,524.86 |
DisclosureSEC source: 0001668397-24-000155 · wk-form4_1724704671.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:18 UTC |
Brady Kevin M.CFO & Treasurer
|
GrantRestricted Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000149 · wk-form4_1723061915.xml · derivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:22 UTC |
BURWIG SUSAN EExec. VP, Operations
|
GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000153 · wk-form4_1723062132.xml · derivative · entry 3 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F3 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:22 UTC |
BURWIG SUSAN EExec. VP, Operations
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001668397-24-000153 · wk-form4_1723062132.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on August 5, 2019. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:22 UTC |
BURWIG SUSAN EExec. VP, Operations
|
Exercise / conversionCommon Stock | 50,000 | $90.65 | $4,532,500.00 |
DisclosureSEC source: 0001668397-24-000153 · wk-form4_1723062132.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:20 UTC |
GEIGER JESSE JPresident
|
GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000151 · wk-form4_1723062024.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:16 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
GrantRestricted Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000147 · wk-form4_1723061786.xml · derivative · entry 2 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:14 UTC |
Troendle August J.Director · CEO · 10% owner
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $377.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000145 · wk-form4_1723061647.xml · derivative · entry 3 Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-08-05 F2 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 17:09 UTC |
Zander Dani S.Director
|
GrantStock Option (Right to Buy) · Derivative | 824 | $0.00 Strike: $407.24 | $0.00 |
DisclosureSEC source: 0001668397-24-000134 · wk-form4_1720040959.xml · derivative · entry 1 Zander Dani S. · CIK 0002029265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 824 Underlying: Common Stock · 824 shares Expires 2031-07-01 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:06 UTC |
Carley Brian TDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 78 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000125 · wk-form4_1719950755.xml · derivative · entry 2 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156 Underlying: Common Stock · 78 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:06 UTC |
Carley Brian TDirector
|
Exercise / conversionCommon Stock | 78 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001668397-24-000125 · wk-form4_1719950755.xml · nonDerivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:17 UTC |
McCarthy Cornelius P. IIIDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000129 · wk-form4_1719951463.xml · derivative · entry 2 McCarthy Cornelius P. III · CIK 0001750355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124 Underlying: Common Stock · 62 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.